{
    "nct_id": "NCT06889168",
    "official_title": "A Phase 1, Randomized, Double-blinded, Placebo Controlled, Trial Evaluating the Long-term Safety and Tolerability of Imatinib for the Treatment of Lymphangioleiomyomatosis [LAMP-2 Trial]",
    "inclusion_criteria": "* Women 18 through 64 years of age (inclusive)\n* Pulmonary Function Test (PFT) with following criteria:\n\n  1. DLCO >20% predicted and FVC <90% OR\n  2. Post bronchodilator FEV1 between 30% and 90% predicted.\n* Confirmed or possible diagnosis of LAM\n* Willing to avoid grapefruit juice and St. John's wort while in the study\n* Able and willing to comply with the study procedures\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 64 Years",
    "exclusion_criteria": "* Women who have or will undergo a transplant\n* Women who will undergo surgery\n* Women who are currently pregnant or plan on a pregnancy\n* Women who are currently breast feeding or lactating\n* Dementia or other cognitive dysfunction that, in the opinion of the investigator, would prevent the participant from consenting to the study or completing study procedures\n* Currently taking any of the following medications:\n\n  * Antifungal Medications: Ketoconazole; Itraconazole ; Voriconazole.\n  * Antibiotics for bacterial infections: Clarithromycin.\n  * Analgesics to treat headaches/migraines: Dihydroergotamine; Dihydroergotamine intranasal\n  * Antiretroviral protease inhibitors used in human immunodeficiency virus (HIV) infections: Atazanavir ; Nelfinavir; Indinavir; Ritonavir; Saquinavir\n  * Anti-epileptic or seizure medications: Carbamazepine, Fosphenytoin; Oxcarbamazepine; Phenobarbital ; Phenytoin; Primidone\n  * Anti-depressant medications: Nefazodone; St. John's wort\n  * Targeted cancer drugs: Regorafenib; Venetoclax ; Cobimetinib\n  * Ivabradine (used to treat chronic heart failure); Telithromycin (used to treat community acquired pneumonia); Lomitapide (treatment of familial hypercholesterolemia); Lonafarnib (Hutchinson-Gilford progeria syndrome); conivaptan (treat low sodium levels); flibanserin (management of hypoactive sexual desire disorder (HSDD)); Naloxegol (opioid-induced constipation); Warfarin (prevent blood clots); Lurasidone (schizophrenia and bipolar depression); Eliglustat (treatment of Gaucher's disease).\n* Non English speaking, illiterate, or other vulnerable persons will not be included among study subjects.\n* Any condition that in the opinion of the investigator might adversely influence the study outcome.",
    "miscellaneous_criteria": ""
}